Recruiting Fanconi Anemia Studies in Vista
A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of OnabotulinumtoxinA, JUVÉDERM® Products, KYBELLA, CoolSculpting Elite and SkinMedica Products
A study to evaluate overall participant satisfaction of face and neck appearance after treatment with onabotulinumtoxinA, JUVÉDERM® products, KYBELLA, CoolSculpting Elite, and select SkinMedica produc...
AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
This is a Phase 2 dose-finding study in adult participants with symptomatic HFpEF....
About Fanconi Anemia Clinical Trials in Vista
Fanconi anemia is a rare genetic disorder that affects bone marrow, reducing production of all types of blood cells and increasing cancer susceptibility. It is associated with physical abnormalities and organ defects. Treatment includes blood transfusions, growth factors, and stem cell transplant.
There are currently 2 fanconi anemia clinical trials recruiting participants in Vista, CA. These studies are seeking a combined 160 participants. Research is being sponsored by AbbVie, Cytokinetics. Clinical trial participation is free and participants receive study-related medical care at no cost.
Fanconi Anemia Clinical Trials in Vista — FAQ
Are there fanconi anemia clinical trials in Vista?
Yes, there are 2 fanconi anemia clinical trials currently recruiting in Vista, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Vista?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Vista research site will contact you about next steps.
Are clinical trials in Vista free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Vista studies also compensate for your time and travel.
What fanconi anemia treatments are being tested?
The 2 active trials in Vista are testing new therapies including novel drugs, biologics, and treatment approaches for fanconi anemia.
Data updated March 2, 2026 from ClinicalTrials.gov